OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
November 16, 2023
Lonza’s new GS Effex cell line can help overcome the challenges of developing therapeutic antibodies with increased potency.
November 02, 2023
As part of a $30 million investment, Aragen is setting up a new biologics manufacturing facility in Bangalore, India.
There is no such thing as a perfect linker.
Re-evaluating the basics of mAb production may be beneficial for the biopharma industry as a whole.
September 02, 2023
Image analysis algorithms coupled with microscopy techniques can be used to characterize aggregates of therapeutic proteins.
July 12, 2023
Exploring new fields can bring novel antibody candidates to the pipeline.
July 06, 2023
Chime Biologics, Leads Biolabs, and BeiGene have formed a three-way collaboration to advance the development and global manufacturing of Leads Biolabs’ lead mAb candidate, LBL-007.
July 02, 2023
Use of a small-scale filler can result in increased filling efficiency.
June 02, 2023
New fields are being explored to bring novel antibody candidates to the pipeline.
Compliance with GMP standards remains an integral focus in bulk mAb manufacturing.